comparemela.com

Latest Breaking News On - Professor cusi - Page 1 : comparemela.com

Inventiva S A (NASDAQ:IVA) Q4 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Inventiva Annual Results 2023 conference call. At this time, all participants are in a listen-only mode.

South koreaUnited statesSteve harrisonSino biopharmPierre broquaSeamus fernandezJean volatierEuropean investment bankValuerich incQatar holdingUniversity of floridaCall transcript marchInventiva annual resultsPrivate securities litigation reform actCo founder pierreProfessor cusi

Inventiva S A (NASDAQ:IVA) Q4 2022 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Inventiva 2022 Full Year Results Call and Webcast. At this time, all participants are in listen-only mode.

United statesNoord hollandSouth africaJean volatierAnnabel samimyMichael cooremanSino biopharmSeamus fernandezLucy luEuropean medicines agencyUniversity of floridaAcademic medical centerValuerich incEuropean investment bankMost promising clean energy stocksCall transcript march

Inventiva reports its 2022 first-half financial results and

Cash position1 at €87.2 million as of June 30, 2022, compared to €95.4 million as of December 31, 2021 Receipt of a €4 million milestone payment from.

New yorkUnited statesFrance generalUnited kingdomCity ofChampagne ardenneSino biopharmPascaline clercPatricial bankBrunswick groupExchange commission onChia tai tianqing pharmaceutical groupUniversity of floridaMarket programGlobal external affairsFrench research

INVENTIVA: Inventiva reports its 2022 first-half financial results and provides a corporate update

Cash position1 at €87.2 million as of June 30, 2022, compared to €95.4 million as of December 31, 2021 Receipt of a €4 million milestone payment from Inventiva's partner AbbVie for cedirogant Phase IIb

New yorkUnited statesFrance generalUnited kingdomCity ofChampagne ardenneSino biopharmPascaline clercPatricial bankBrunswick groupExchange commission onChia tai tianqing pharmaceutical groupUniversity of floridaMarket programGlobal external affairsFrench research

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva reports its 2022 first-half financial results and provides a corporate update

Investegate announcements from INVENTIVA, Inventiva reports its 2022 first-half financial results and provides a corporate update

New yorkUnited statesFrance generalUnited kingdomCity ofChampagne ardenneSino biopharmPascaline clercPatricial bankBrunswick groupExchange commission onChia tai tianqing pharmaceutical groupUniversity of floridaMarket programGlobal external affairsFrench research

vimarsana © 2020. All Rights Reserved.